Bioresonance Q and A: the MHRA answers HealthSense’s questions

Citation. HealthSense UK. Bioresonance Q&A: the MHRA answers our questions. HealthSense newsletter 116. Date not shown on the page.

Type. Regulator correspondence published by a consumer group.

What it says. The MHRA states that bioresonance has no defined regulatory status as a category, that status depends on the claims made for a particular device, and that a CE mark is not proof of efficacy.

Read the original. healthsense-uk.org newsletter 116

This entry describes what the regulator says. It is not a claim by this site that bioresonance diagnoses or treats any condition.

David Franklin

David Franklin is an advocate of Bioresonance therapy. He has seen how this form of treatment has helped his wife Sarah, who suffers from Addisons disease. David supplies Bicom Optima devices to therapists all over the world, and he also trains them on how to use the medical equipment effectively.

See Full Bio